Related Experiment Video
Updated: Feb 11, 2026
09:08
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
7.2K
DACT1 as a Potential Therapeutic Target in Gastric Cancer: Insights from Integrative Bioinformatics and Experimental
Rui-Sheng Ke1, Bing Bai1, Yan-Ling Tu2
1Department of General Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, Fujian, China.
Summary
Dapper Antagonist of β-Catenin-1 (DACT1) is highly expressed in gastric cancer (GC), correlating with poor survival. Inhibiting DACT1 suppressed GC cell growth, migration, and key cancer pathways, suggesting DACT1 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer (GC) is a major global health concern.
- The gene Dapper Antagonist of β-Catenin-1 (DACT1) has been implicated in various cancers.
- Understanding DACT1's role in GC is crucial for developing new treatments.
Purpose of the Study:
- To investigate the expression of DACT1 in gastric cancer.
- To analyze the correlation between DACT1 and GC patient prognosis.
- To explore the functional role of DACT1 in GC cell lines and its associated signaling pathways.
Main Methods:
- Bioinformatics analysis using multiple databases.
- Cell culture of GC cell lines.
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) and Western Blotting.
- DACT1 knockdown experiments.
Main Results:
- DACT1 was found to be highly expressed in GC and associated with lower overall survival rates.
- DACT1 expression correlated with epithelial-mesenchymal transition (EMT) and Notch signaling pathways.
- Knockdown of DACT1 significantly inhibited GC cell proliferation, migration, EMT, and Notch pathway activity.
Conclusions:
- DACT1 plays a significant role in gastric cancer progression.
- DACT1 influences GC through EMT and Notch signaling.
- DACT1 represents a promising therapeutic target for gastric cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:16Gastric Motility
3.2K
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
3.2K
01:21Cancer Survival Analysis
774
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
774
01:16Gastric Emptying
3.9K
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
3.9K
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
213
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
213
01:26Gastric Phase of Digestion
3.5K
The gastric phase of digestion begins as soon as food enters the stomach. The incoming food bolus triggers neural and hormonal mechanisms, which last approximately 3 to 4 hours. During this phase, the stomach undergoes significant changes to prepare the food for further digestion and absorption.
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
3.5K